Patent · US Active

Lipidated glycosaminoglycan particles for the delivery of nucleic acids

US9925143B2 · kind B2 · utility

0Cited by
78References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 14, 2013
Grant dateMar 27, 2018
Priority date—
Expiry dateMar 14, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are provided compositions comprising lipidated glycosaminoglycan particles, methods for their preparation and uses thereof for the efficient in-vivo and in-vitro delivery of nucleic acids, such as, siRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.